ImmunoSite Technologies » Scientific Studies http://immunositetechnologies.com Services in Assay Automation, Particle Testing, Medical Device Product Development Mon, 25 Feb 2019 21:18:55 +0000 en-US hourly 1 http://wordpress.org/?v=3.6.1 Feasibility study: Improving Cryopreservation of PBMC for More Reliable Information From Clinical Trials http://immunositetechnologies.com/library/scientific-studies/feasibility-study-improving-cryopreservation-of-pbmc-for-more-reliable-information-from-clinical-trials/ http://immunositetechnologies.com/library/scientific-studies/feasibility-study-improving-cryopreservation-of-pbmc-for-more-reliable-information-from-clinical-trials/#comments Sat, 29 Jun 2013 14:35:36 +0000 ImmunoSite Technologies http://immunositetechnologies.com/?p=1833 Automation of Cryopreservation (Cell Freezing) AND Cell Thawing is a Reality for PBMCs!

ImmunoSite Technologies and MéCour have partnered to advance the automation of difficult and variable processes for cell handling by improving the quantity and quality of the PBMC yields and viability through automation.  The capability of freezing and thawing PBMC using the precisely controlled freezing rate in the MéCour system, coupled with an automated liquid handler,  facilitates the complete automation of  isolating cells, counting cells, loading the cells into cryovials, and freezing cells with automated precision. The enhanced throughput of cell isolation and handling processes allow larger and more diverse clinical studies.  DOWNLOAD the whitepaper now for all the details.

Share this:
  • Print
  • Digg
  • Facebook
  • email
  • LinkedIn
  • Twitter
]]>
http://immunositetechnologies.com/library/scientific-studies/feasibility-study-improving-cryopreservation-of-pbmc-for-more-reliable-information-from-clinical-trials/feed/ 0
Assay Automation Ability – Lyophilized reagents for in vitro whole blood assays http://immunositetechnologies.com/library/scientific-studies/assay-automation-ability-lyophilized-reagents-for-in-vitro-whole-blood-assays/ http://immunositetechnologies.com/library/scientific-studies/assay-automation-ability-lyophilized-reagents-for-in-vitro-whole-blood-assays/#comments Mon, 07 May 2012 13:16:57 +0000 ImmunoSite Technologies http://immunositetechnologies.com/?p=1567

Utility of lyophilized PMA and ionomycin to stimulate lymphocytes in whole blood for immunological assays


Belouski, S. S.*, Wilkinson, J.^, Thomas, J.*, Kelley, K.*, Wang, S.-W.*, Suggs, S.* and Ferbas, J.* (2010), . Cytometry, 78B: 59–64.

doi: 10.1002/cyto.b.20492

 

The need to implement robust biomarkers in clinical trials has never been greater, and such efforts can be easily compromised by reagent instability or simple human error during assay set-up. Many biotechnology and pharmaceutical companies are introducing efforts to conduct biomarker studies under more rigorous settings, and the use of plates or tubes pre-loaded with stimulation or staining reagents could be of value for studies that involve flow cytometry.

Author Information:
* Amgen Inc., Department of Medical Sciences
^ Beckman Coulter Inc., Custom BioPharma Group, Miami, Florida (author Julie Wilkinson current address is ImmunoSite Technologies, Fort Lauderdale, FL)
Email: John Ferbas (jferbas@amgen.com)
*One Amgen Center Drive, Mailstop 30E-3-C, Thousand Oaks 91320-1799, CA
Share this:
  • Print
  • Digg
  • Facebook
  • email
  • LinkedIn
  • Twitter
]]>
http://immunositetechnologies.com/library/scientific-studies/assay-automation-ability-lyophilized-reagents-for-in-vitro-whole-blood-assays/feed/ 0
Research Poster – Assay Standardization Saves Money http://immunositetechnologies.com/library/scientific-studies/poster/ http://immunositetechnologies.com/library/scientific-studies/poster/#comments Tue, 23 Aug 2011 19:38:09 +0000 MM-CSL http://immunositetechnologies.com/?p=1449 The identification and application of correlates of immune response can enable significant time and money savings especially in clinical trial settings for vaccine and biologic R&D.

To download, please fill in the form below:

[email-download download_id="2" contact_form_id="3"]

Share this:
  • Print
  • Digg
  • Facebook
  • email
  • LinkedIn
  • Twitter
]]>
http://immunositetechnologies.com/library/scientific-studies/poster/feed/ 0
Validation of Cell-Based Assays in the GLP Setting http://immunositetechnologies.com/library/blog/cell-based-assays-in-the-glp-setting/ http://immunositetechnologies.com/library/blog/cell-based-assays-in-the-glp-setting/#comments Tue, 11 Jan 2011 02:14:14 +0000 ImmunoSite Technologies http://immunositetechnologies.com/?p=788 Validation of Cell based assays in GLP setting

IST quite literally helped “write the book” on cell analysis testing.  They were asked to contribute a chapter of a book titled Validation of Cell-Based Assays in the GLP Setting: A Practical Guide, by authors/editors Uma Prabhakar and Marian Kelley (Publisher John Wiley and Sons, 2008, ISBN 0470028769, 9780470028766).  Chapter 8 of this book entitled “Intracellular cytokine detection by flow cytometry” was authored by IST scientists Julie G. Wilkinson, Carlos L. Aparicio, and Wade E. Bolton.

Readers gain an understanding of the details and the high level considerations of assay qualification for difficult cell-based assays.  The level of optimization described for cell-based assays lends itself to biomarker assay automation which can be used for biomarker qualification and validation studies to the satisfaction of the FDA, EMEA, and other regulatory agencies.   Cell-based assay platforms covered are flow cytometry, intracellular cytokine ICS, immunophenotyping, elispot, IHC, cylex, neutralization bioassays, and endpoint assays.

Share this:
  • Print
  • Digg
  • Facebook
  • email
  • LinkedIn
  • Twitter
]]>
http://immunositetechnologies.com/library/blog/cell-based-assays-in-the-glp-setting/feed/ 0